Beta-Galactosidase, Leukocytes
CHIC2, 4q12 Deletion (FIP1L1 and PDGFRA Fusion), FISH, Blood
1,3-Beta-D-Glucan (Fungitell® ß-D Glucan), CSF
Chromosome Analysis, Solid Tumors
Insulin, Free and Total
6-Monoacetylmorphine (6-MAM) Confirmation, Meconium
Potassium, 24 Hour, Urine
Alpha-galactosidase A (GLA) Mutation Analysis
Nalbuphine, Urine
Bladder Tumor Antigen (BTA)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
15q Deletion, Type I and Type II Characterization, Prader-Willi/Angelman Syndromes, FISH
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
15q Deletion, Type I and Type II Characterization, Prader-Willi/Angelman Syndromes, FISH
Medical Test
Diseases (2)
Access to
15q Deletion, Type I and Type II Characterization, Prader-Willi/Angelman Syndromes, FISH
is restricted.
Sign up now
Loading...